Search :
Sign in or Register  
Welcome Sign in or Don't have an account?Register

Mouse Anti-EGFL7 (AA 24-273) Recombinant Antibody (CBFYE-0542) (CBMAB-E0907-FY)


See all EGFL7 antibodies
Online Inquiry

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBFYE-0542
Antibody Isotype
IgG2b, κ
Application
ELISA, WB

Basic Information

Immunogen
EGFL7 full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. Immunogen sequence: YRPGRRVCAV RAHGDPVSES FVQRVYQPFL TTCDGHRACS TYRTIYRTAY RRSPGLAPAR PRYACCPGWK RTSGLPGACG AAICQPPCRN GGSCVQPGRC RCPAGWRGDT CQSDVDERSA RRGGCPQRCI NTAGSYWCQC WEGHSLSADG TLCVPKGGPP RVAPNPTGVD SAMKEEVQRL QSRVDLLEEK LQLVLAPLHS LASQALEHGL PDPGSLLVHS FQQLGRIDSL SEQISFLEEQ LGSCSCKKDS
Specificity
Human
Antibody Isotype
IgG2b, κ
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS, pH 7.4
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Epitope
AA 24-273

Target

Full Name
EGF Like Domain Multiple 7
Introduction
This gene encodes a secreted endothelial cell protein that contains two epidermal growth factor-like domains. The encoded protein may play a role in regulating vasculogenesis. This protein may be involved in the growth and proliferation of tumor cells. Alternate splicing results in multiple transcript variants.
Entrez Gene ID
51162
UniProt ID
Q9UHF1
Alternative Names
EGF Like Domain Multiple 7; Multiple Epidermal Growth Factor-Like Domains Protein 7; Multiple EGF-Like Domains Protein 7; Vascular Endothelial Statin; NOTCH4-Like Protein; EGF-Like Protein 7; VE-STATIN
Research Area
Regulates vascular tubulogenesis in vivo. Inhibits platelet-derived growth factor (PDGF)-BB-induced smooth muscle cell migration and promotes endothelial cell adhesion to the extracellular matrix and angiogenesis.
Biological Process
Anatomical structure development Source: GO_Central
Angiogenesis Source: UniProtKB-KW
Blood vessel development Source: UniProtKB
Cell adhesion Source: UniProtKB-KW
Negative regulation of Notch signaling pathway Source: MGI
Positive regulation of endothelial cell proliferation Source: MGI
Vasculogenesis Source: UniProtKB
Cellular Location
Extracellular space
More Infomation

Ortega, M. A., Asunsolo, A., Fraile‑Martínez, O., Sainz, F., Saez, M. A., Bravo, C., ... & García‑Honduvilla, N. (2021). An increase in elastogenic components in the placental villi of women with chronic venous disease during pregnancy is associated with decreased EGFL7 expression level. Molecular medicine reports, 24(2), 1-9.

Heissig, B., Salama, Y., Takahashi, S., Okumura, K., & Hattori, K. (2021). The multifaceted roles of EGFL7 in cancer and drug resistance. Cancers, 13(5), 1014.

Massimiani, M., Salvi, S., Tiralongo, G. M., Moresi, S., Stuhlmann, H., Valensise, H., ... & Campagnolo, L. (2021). Circulating EGFL7 distinguishes between IUGR and PE: An observational case–control study. Scientific Reports, 11(1), 1-8.

Bill, M., Pathmanathan, A., Karunasiri, M., Shen, C., Burke, M. H., Ranganathan, P., ... & Dorrance, A. M. (2020). EGFL7 Antagonizes NOTCH Signaling and Represents a Novel Therapeutic Target in Acute Myeloid LeukemiaTargeting EGFL7 in AML. Clinical Cancer Research, 26(3), 669-678.

Liu, Q., He, H., Yuan, Y., Zeng, H., Wang, Z., & Luo, W. (2020). Novel expression of EGFL7 in osteosarcoma and sensitivity to cisplatin. Frontiers in Oncology, 10, 74.

Usuba, R., Pauty, J., Soncin, F., & Matsunaga, Y. T. (2019). EGFL7 regulates sprouting angiogenesis and endothelial integrity in a human blood vessel model. Biomaterials, 197, 305-316.

Richter, A., Alexdottir, M. S., Magnus, S. H., Richter, T. R., Morikawa, M., Zwijsen, A., & Valdimarsdottir, G. (2019). EGFL7 mediates BMP9-induced sprouting angiogenesis of endothelial cells derived from human embryonic stem cells. Stem cell reports, 12(6), 1250-1259.

Larochelle, C., Uphaus, T., Broux, B., Gowing, E., Paterka, M., Michel, L., ... & Zipp, F. (2018). EGFL7 reduces CNS inflammation in mouse. Nature communications, 9(1), 1-12.

Dudvarski Stanković, N., Bicker, F., Keller, S., Jones, D. T., Harter, P. N., Kienzle, A., ... & Schmidt, M. H. (2018). EGFL7 enhances surface expression of integrin α5β1 to promote angiogenesis in malignant brain tumors. EMBO molecular medicine, 10(9), e8420.

Hong, G., Kuek, V., Shi, J., Zhou, L., Han, X., He, W., ... & Xu, J. (2018). EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis. Journal of cellular physiology, 233(11), 8526-8537.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-EGFL7 (AA 24-273) Recombinant Antibody (CBFYE-0542)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Learn more

Documents

Request bulk or custom quote Online Inquiry
Second antibody and isotype control

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Online Inquiry